Abbott Laboratories vs Danaher

Abbott Laboratories (ABT), health care, and Danaher (DHR), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Abbott Laboratories is worth $184.1B on the stock market and Danaher $159.2B: Abbott Laboratories is valued at 16% more. Abbott Laboratories trades at 39.7 times earnings and Danaher at 37.5; operating margins in their latest fiscal years were 18.2% and 19.1%. Over the past year Abbott Laboratories's share price has moved -17.3% and Danaher's +1.95%.

Key facts

Abbott Laboratories market value
$184.1B
Danaher market value
$159.2B
Abbott Laboratories P/E
39.7
Danaher P/E
37.5
Abbott Laboratories revenue
$44.3BFY to 2025-12-31
Danaher revenue
$24.6BFY to 2025-12-31
Superinvestors holding both
2

Market values as of .

Abbott Laboratories vs Danaher: every measure side by side
Measure Abbott Laboratories Danaher
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$184.1Bhigher$159.2Blower
Revenue$44.3Bhigher$24.6Blower
Earnings$6.5Bhigher$3.6Blower
Employees122,000higher58,000lower
Total assets$86.7Bhigher$83.5Blower
Valuation
P/E39.7higher37.5lower
P/S4.2lower6.5higher
P/B3.6higher3.0lower
Dividend yield2.35%higher0.66%lower
Profitability
Operating margin18.2%lower19.1%higher
Balance sheet
Net assets$52.1Blower$52.5Bhigher
Total liabilities$33.9Bhigher$30.9Blower
Total debt$12.9Blower$18.4Bhigher
Cash on hand$8.5Bhigher$4.6Blower
Price change
Today-1.09%higher-1.57%lower
1 year-17.3%lower+1.95%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Abbott Laboratories / Danaher). Who owns ABT · Who owns DHR

Further comparisons

Learn

Questions and answers

Which is bigger, Abbott Laboratories or Danaher?

By market value, Abbott Laboratories is the larger: $184.1B against $159.2B for Danaher. By revenue in its latest fiscal year, Abbott Laboratories is the larger: $44.3B against $24.6B for Danaher.

Which has the higher P/E ratio?

Abbott Laboratories: 39.7, against 37.5 for Danaher. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Danaher: 19.1%, against 18.2% for Abbott Laboratories. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Abbott Laboratories: 2.35%, against 0.66% for Danaher. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Danaher: $18.4B, against $12.9B for Abbott Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Abbott Laboratories and Danaher?

In their latest 13F filings, Brandon Haley and Israel Englander hold both.

Cite this page

Funkfolio, “Abbott Laboratories vs Danaher”, data as of 17 November 2026. https://funkfolio.com/compare/abt-vs-dhr

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.